ArticleFrontiers in medicine2025
Study protocol for impact of visual inhaler technique instructions on short-term outcomes in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute exacerbations (AEs) are key events in the progression of chronic obstructive pulmonary disease (COPD), accelerating the decline in lung function and increasing mortality considerably. Inhaler therapy is essential for COPD management; however, incorrect use of inhalation techniques can reduce drug efficacy and increase AE frequency. To optimize the effectiveness of inhaler use, we aim to conduct a randomized controlled trial, in which short-term visual instructions for inhalation use are provided to hospitalized patients with AE of COPD (AECOPD) to reduce AE frequency and severity within 12 weeks. Methods: This will be a single-center, randomized controlled trial including hospitalized patients with AECOPD who meet the inclusion criteria at the China-Japan Friendship Hospital. The patients will be randomly assigned to a visual inhaler technique instruction (VIT; experimental) or traditional inhaler technique education (TIE; control) group. During hospitalization, the TIE group will receive two standardized TIE sessions conducted by a respiratory nurse. In contrast, the VIT group will receive two VIT sessions under a physical therapist's supervision. The primary outcome will be AE frequency within 12 weeks after discharge. Secondary outcomes include all-cause mortality and each AE's severity (EXACT-Pro score) over 12 post-discharge weeks. Secondary outcomes will also include lung function, physical fitness (6-min walk test score, grip strength, and maximum voluntary contraction of knee extension), respiratory muscle strength (maximal inspiratory and expiratory pressures), dyspnea severity (modified Medical Research Council scale score), inhaler medication adherence, and quality of life (COPD Assessment Test score) at week 12 after discharge. Discussion: We aim to address the issues related to inhaler technique education that are often overlooked in clinical practice. Our findings may provide evidence for clinical practice and enable further optimization of inhaler technique education management strategies for patients with AECOPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.